The company anouncement on 05/09/2011 regarding Notice of...

The company anouncement on 05/09/2011 regarding Notice of General Meeting to be held on 7 October 2011 states on page 8:

USE OF FUNDS (Re capital raising) approx that;

10% will be used to further the company's Italian and French trial on non-evasive diagnostic test for the detection of breast cancer.

30% toward the identification of any potential new businesses, and the balance

60% for working capital.

They plan to spend 3x more on potential new businesses that further tests re Italian and French trials.

This I believe along with the appointmet of the two new directors (who both have had extensive involvement not in the Medical field but in the Resource Sector), is a strong indication of the future plans of the company.

Nothing else makes sense IMO.

Yes I hold.